Numerai GP LLC acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 1,353 shares of the medical technology company’s stock, valued at approximately $241,000.
A number of other hedge funds also recently bought and sold shares of the business. Barclays PLC grew its position in shares of Teleflex by 1.6% in the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company’s stock valued at $22,233,000 after purchasing an additional 1,426 shares in the last quarter. Franklin Resources Inc. boosted its stake in Teleflex by 64.3% during the third quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company’s stock worth $2,298,000 after buying an additional 3,790 shares during the last quarter. Principal Financial Group Inc. grew its holdings in Teleflex by 2.7% in the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock valued at $19,887,000 after buying an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Teleflex by 4.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company’s stock worth $588,000 after acquiring an additional 128 shares during the last quarter. Finally, Czech National Bank raised its holdings in shares of Teleflex by 4.9% during the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company’s stock worth $1,792,000 after acquiring an additional 472 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.
Analyst Upgrades and Downgrades
TFX has been the subject of a number of analyst reports. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Mizuho set a $155.00 price target on shares of Teleflex in a research note on Wednesday, April 16th. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Wells Fargo & Company decreased their price objective on Teleflex from $146.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, May 2nd. Finally, Morgan Stanley cut their target price on Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a research note on Monday, May 5th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $164.63.
Teleflex Stock Up 1.1%
NYSE:TFX opened at $126.59 on Friday. Teleflex Incorporated has a 52 week low of $120.06 and a 52 week high of $249.91. The stock’s fifty day moving average is $133.03 and its two-hundred day moving average is $163.88. The stock has a market capitalization of $5.59 billion, a price-to-earnings ratio of 25.17, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.
Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same quarter in the prior year, the company earned $3.21 EPS. Teleflex’s revenue was down 5.0% on a year-over-year basis. Research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex’s payout ratio is 42.90%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Read More
- Five stocks we like better than Teleflex
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Walmart Stock Alert: Big Price Move Expected Soon
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.